Meningitis is an infection (swelling) of the defensive layers that are called meninges covering the brain and spinal cord. Bacterial or viral contagion of the fluid surrounding the brain and spinal cord ordinarily causes the swelling. However, wounds, disease, certain medications, and different kinds of infections can also cause meningitis. Additionally, bacterial meningitis can cause permanent disabilities, such as brain damage and hearing loss if untreated. However, the vast majority of meningitis can prevent with proper vaccination.
MARKET DYNAMICS
The meningitis vaccine market is driving due to the risk of permanent disabilities among children and rise in awareness about proper dose of immunization. However, bacterial resistance to penicillin and lack of access to vaccine approval are likely to restraint the market growth during the forecast period. Moreover, the increase in incidence of meningitis in children is one of the major factors fueling the global meningitis vaccine market.
MARKET SCOPE
The "Meningitis Vaccine Market Analysis to 2028" is a specialized and in-depth study of the pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of meningitis vaccine market with detailed market segmentation vaccine type and distribution channel. The meningitis vaccine market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in meningitis vaccine market and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The meningitis vaccine market is segmented on the basis of vaccine type and distribution channel. Based on vaccine type, the market is segmented as haemophilus influenza type b vaccine, pneumococcal conjugate vaccine, pneumococcal polysaccharide vaccine, meningococcal vaccine, and others. On the basis of distribution channel, the market is categorized as hospital pharmacies, retail pharmacies, and others.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the meningitis vaccine market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The meningitis vaccine market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting meningitis vaccine market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the meningitis vaccine market in these regions.
MARKET PLAYERS
The report covers key developments in the meningitis vaccine market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from meningitis vaccine market are anticipated to have lucrative growth opportunities in the future with the rising demand for meningitis vaccine in the global market. Below mentioned is the list of few companies engaged in the meningitis vaccine market.
The report also includes the profiles of key players in meningitis vaccine market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
- Astellas Pharma Inc.
- Bavarian Nordic
- CSL Limited
- Emergent BioSolutions, Inc.
- GlaxoSmithKline, plc
- Johnson & Johnson
- MedImmune, LLC
- Merck & Co., Inc.
- Mitsubishi Tanabe Pharma Corporation
- Panacea Biotec
- Pfizer, Inc.
- Protein Sciences Corporation
- Sanofi Pasteur SA
- Serum Institute of India Pvt. Ltd.